Bill and Melinda Gates-backed coronavirus vaccine maker soars in Wall Street debut

The Muslim Times

Bill and Melinda The Muslim Times has the best collection of articles for the war against Covid 19, especially the vaccines.

New York (CNN Business) The race for a successful coronavirus vaccine is heating up in labs around the world — and on Wall Street. Germany’s CureVac, a biotech with the backing of the Bill & Melinda Gates Foundation, more than tripled in its first day of trading Friday.

CureVac priced its initial public offering at $16 a share. The stock soared nearly 250%, to just below $56, by the end of the day.

The company, which is competing with the likes of Moderna (MRNA), Novavax (NVAX), BioNTech (BNTX) and Pfizer (PFE), is also backed by billionaire Dietmar Hopp, the co-founder of German software giant SAP (SAP).

Hopp owns nearly half of CureVac. The German government and Big Pharma leader GlaxoSmithKline (GSK) also have big stakes.

Read further

shah_ziaDr. Zia H…

View original post 255 more words

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.